Chronic fluoxetine treatment induces lipid accumulation but does not alter the expression of Pref-1 in rat adipose tissue
By:
References
- 1. S. Adams, D. Heckard, J. Hassell and L. Uphouse, Factors influencing fluoxetine-induced sexual dysfunction in female rats, Behav. Brain Res. 235 (2012) 73-81; https://doi.org/10.1016/j.bbr.2012.07.029
- 2. M. Afkhami-Ardekani and H. Sedghi, Effect of fluoxetine on weight reduction in obese patients, Indian J. Clin. Biochem. 20 (2005) 135-138.
- 3. S. R. Blumenthal, V. M. Castro, C. C. Clements, H. R. Rosenfield, S. N. Murphy, M. Fava, J. B. Weilburg, J. L. Erb, S. E. Churchill, I. S. Kohane, J. W. Smoller and R. H. Perlis, An electronic health records study of long-term weight gain following antidepressant use, JAMA Psychiatry 71 (2014) 889-896; https://doi.org/10.1001/jamapsychiatry.2014.414
- 4. J. P. Domecq, G. Prutsky, A. Leppin, M. B. Sonbol, O. Altayar, C. Undavalli, Z. Wang, T. Elraiyah, J. P. Brito, K. F. Mauck, M. H. Lababidi, L. J Prokop, N. Asi, J. Wei, S. Fidahussein, V. M. Montori and M. H. Murad, Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis, J. Clin. Endocrinol. Metab. 100 (2015) 363-370; https://doi.org/10.1210/jc.2014-3421
- 5. C. S. Hudak and H. S. Sul, Pref-1, a gatekeeper of adipogenesis, Front. Endocrinol. 4 (2013) 1-6; https://doi.org/10.3389/fendo.2013.00079
- 6. S. Caccia, M. Cappi, C. Fracasso and S. Garattini, Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat, Psychopharmacology (Berlin) 100 (1990) 509-514.
- 7. N. W. Jacobsen, C. H. Hansen, C. Nellemann, B. Styrishave and B. Halling-Sørensen, Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay, Toxicol. in Vitro 29 (2015) 1729-1735; https://doi.org/10.1016/j.tiv.2015.07.005
- 8. B. K. Sun, J. H. Kim, J. S. Choi, S. J. Hwang and J. H. Sung, Fluoxetine decreases the proliferation and adipogenic differentiation of human adipose-derived stem cells, Int. J. Mol. Sci. 16 (2015) 16655-16668; https://doi.org/10.3390/ijms160716655
- 9. M. Kolcsár, Z. Gáll, I. L. Bíró, L. I. Bába, A. Imre, M. T. Dogaru and O. Martha, Fluoxetine influence on body weight, serum adiponectin level and adipose tissue triglycerides levels in rats, Farmacia 6 (2016) 599-604.
- 10. A. K. Stunes, J. E. Reseland, O. Hauso, M. Kidd, K. Tommeras, H. L. Waldum, U. Syversen and B. I. Gustafsson, Adipocytes express a functional system for serotonin synthesis, reuptake and receptor activation, Diabetes Obes. Metab. 13 (2011) 551-558; https://doi.org/10.1111/j.1463-1326.2011.01378.x
- 11. S. Grès, S. Canteiro, J. Mercader and C. Carpéné, Oxidation of high doses of serotonin favors lipid accumulation in mouse and human fat cells, Mol. Nutr. Food Res. 57 (2013) 1089-1099; https://doi.org/10.1002/mnfr.201200681
- 12. S. Grès, S. Gomez-Zorita, A Gomez-Ruiz and C. Carpene, 5-Hydroxytryptamine actions in adipocytes: involvement of monoamine oxidase-dependent oxidation and subsequent PPARγ activation, J. Neural. Transm. (Vienna) 120 (2013) 919-926; https://doi.org/10.1007/s00702-012-0959-8
Language: English
Page range: 109 - 115
Accepted on: Nov 27, 2017
Published on: Feb 16, 2018
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2018 László-István Bába, Zsolt Gáll, István Lóránt Bíró, Tibor Mezei, Imre Zoltán Kun, Melinda Kolcsár, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.